How would you treat metastatic colon cancer in patients on dialysis?
What would you consider in the first and second line settings with intact MMR/MSI?
2 Answers
Mednet MemberInvited Expert
Medical Oncology · Johns Hopkins University School of Medicine
Answered on
Fortunately, our standard regimen of 5FU and oxaliplatin are quite safe to administer for patients with chronic renal insufficiency/on dialysis:
- 5FU is cleared through non-renal mechanisms and does not require any dose adjustments
- BUT...exposure to capecitabine is higher in patients with renal i...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · Rutgers Cancer Institute of New Jersey
Answered on
I generally agree with Dr Pishvaian. I would like to emphasize that capecitabine is completely contraindicated. Dose should be reduced for GFR < 30 ml/min but this is not safe for dialysis patients and cannot be given on a continuous basis.
Neither FU or platinums need any dose adjustment and I usua...
Join for free or sign in to see the full answer